CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 380 enrolled
Drug / intervention
Silver-impregnated antimicrobial dressingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03136159
NCT03136159N/ACompleted
CompareCT.gov

The Role of Adherent Occlusive Antimicrobial Absorbent Foam Dressing in Prevention of Cesarean Section Wound Complications

Loyola University·interventional·Posted May 2, 2017·Updated Dec 21, 2020

In Brief

A clinical study evaluating Silver-impregnated antimicrobial dressing for Cesarean Section; Complications, Wound, Dehiscence. Completed, enrolled 380 participants across 1 site.

Detailed Summary

Post-cesarean section wound infections are responsible for longer hospital stays, readmissions, and ultimately, increased costs to the healthcare system. Silver-containing dressings may prevent wound infections. The purpose of the current study is to determine if the use of a silver-impregnated dressing decreases the occurence of wound infection following cesarean delivery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCesarean Section; Complications, Wound, Dehiscence
CountriesUnited States
CollaboratorsMolnlycke Health Care AB

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2, 2017
Enrollment StartJul 24, 2017
Primary CompletionJun 30, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.2 years ago

Interventions

Silver-impregnated antimicrobial dressingdevice

All participants will receive an adherent soft silicone silver impregnated anti-microbial occlusive foam dressing after cesarean section. The dressing will stay on for up to seven days.